GlassScriptPhysician profile
Issra Jamal
NPI 1457792871
$2,016.43
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $591 · 2021: $736.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $284.19 | 2019-2021 | |
| Novo Nordisk INC | $244.27 | 2019-2021 | |
| Amgen INC. | $219.91 | 2019-2021 | |
| Valeritas, INC. | $160.74 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $131.21 | 2019-2021 | |
| Corcept Therapeutics | $131.17 | 2021 | |
| Mannkind Corporation | $118.30 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $114.71 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $95.35 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $66.39 | 2019-2020 | |
| Horizon Therapeutics Plc | $62.76 | 2019-2020 | |
| Radius Health, INC. | $60.34 | 2019 | |
| Amarin Pharma, INC. | $52.74 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.02 | 2020 | |
| Abbott Laboratories | $50.31 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $49.91 | 2019 | |
| Insulet Corporation | $21.92 | 2021 | |
| Zealand Pharma US, INC. | $21.13 | 2020 | |
| Tandem Diabetes Care, INC. | $20.82 | 2021 | |
| Vifor Pharma, INC. | $16.94 | 2020 | |
| Mallinckrodt Enterprises LLC | $14.37 | 2019 | |
| Mallinckrodt Hospital Products INC. | $14.00 | 2020 | |
| Companion Medical, INC. | $12.93 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Issra Jamal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.